STE Net Profit Margin	(Sep 30 2025) Q2	(Jun 30 2025) Q1	(Mar 31 2025) Q4	(Dec 31 2024) Q3	(Sep 30 2024) Q2
Y / Y Revenue Change	9.89 %	8.72 %	4.31 %	-1.8 %	-1 %
Seq. Revenue Change	4.97 %	-6.04 %	8.02 %	3.13 %	3.86 %
Revenue In Millions	$1,460.30	$1,391.10	$1,480.53	$1,370.57	$1,328.91
Net Profit Margin	13.18 %	12.8 %	9.87 %	12.64 %	11.38 %
Net Profit Margin Total Ranking	# 1141	# 1082	# 1299	# 1240	# 1234
Net Income In Millions	$192.50	$178.00	$146.08	$173.29	$151.17
Y / Y Net Income Change	27.34 %	22.3 %	-	22.95 %	29.93 %
Seq. Net Income Change	8.15 %	21.86 %	-15.7 %	14.63 %	3.87 %

New: More STE's historic Net Margin results >>

Commenting Second Quarter 2025 Net Profit Margin

Steris Plc Net Income grew by 8.15 % in Q2 sequentially to 193 millions, while Revenue increased by 4.97 %, this led to improvement in the company's Net Profit Margin to 13.18 %, above the Steris Plc average Net Profit Margin.

Observing second quarter 2025 results within Medical Equipment & Supplies industry 27 other companies have achieved higher Net Profit Margin. While Net Profit Margin overall ranking has deteriorated relative to the three months before, from 1082 to 1141.
Net Margin Formula

STE's Net Profit Margin second quarter 2025 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 28
Healthcare Sector	# 105
Overall	# 1141

Net Profit Margin Statistics
High	Average	Low
14.4 %	9.1 %	1.77 %
(Dec 31 2017)

STE Earnings Outlook • STE Net Income Results by quarter • Compare STE's Net Margin

Other Net Profit Margin Profitability Ratios
STE's Cumulative Net Profit Margin
Medical Equipment & Supplies Industry Net Profit Margin Trends and Statistics
Healthcare Sector Net Profit Margin Statistics
Net Profit Margin Profitability Trends for overall market
STE's Net Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Profit Margin
Lowest Ranking Net Profit Margin
Net Profit Margin Profit Margin for STE's Competitors
Net Profit Margin Profit Margin for Steris Plc's Suppliers
Net Profit Margin Profit Margin for STE's Customers

You may also want to know
STE's Annual Growth Rates	STE's Profitability Ratios	STE's Asset Turnover Ratio	STE's Dividend Growth
STE's Roe	STE's Valuation Ratios	STE's Financial Strength Ratios	STE's Net Income Growth
STE's Roa	STE's Inventory Turnover Ratio	STE's Growth Rates	STE's Dividend Comparisons

Companies with similar Net Profit Margin in the quarter ending Sep 30 2025, within Medical Equipment & Supplies Industry	Net Profit Margin	Sep 30 2025 MRQ Net Income	Sep 30 2025 MRQ Revenue
Lemaitre Vascular Inc	28.48 %	$ 17.362 Millions	$ 60.955 Millions
Intuitive Surgical Inc	28.32 %	$ 709.200 Millions	$ 2,504.400 Millions
Utah Medical Products Inc	27.39 %	$ 2.631 Millions	$ 9.604 Millions
Iradimed Corporation	26.30 %	$ 5.577 Millions	$ 21.202 Millions
Resmed Inc	26.27 %	$ 348.536 Millions	$ 1,326.820 Millions
Pro dex Inc	25.26 %	$ 4.680 Millions	$ 18.530 Millions
Dexcom Inc	23.49 %	$ 283.800 Millions	$ 1,208.400 Millions
Nuwellis Inc	21.20 %	$ 0.470 Millions	$ 2.217 Millions
Edwards Lifesciences Corporation	18.69 %	$ 290.300 Millions	$ 1,552.900 Millions
West Pharmaceutical Services Inc	17.41 %	$ 140.000 Millions	$ 804.300 Millions
Transmedics Group Inc	16.91 %	$ 24.319 Millions	$ 143.823 Millions
Alpha Pro Tech Ltd	16.36 %	$ 2.269 Millions	$ 13.868 Millions
Carlisle Companies Incorporated	15.90 %	$ 214.200 Millions	$ 1,346.900 Millions
Globus Medical Inc	15.47 %	$ 118.966 Millions	$ 769.048 Millions
Medtronic Plc	15.41 %	$ 1,381.000 Millions	$ 8,961.000 Millions
Boston Scientific Corporation	14.91 %	$ 755.000 Millions	$ 5,065.000 Millions
Msa Safety Inc	14.89 %	$ 69.613 Millions	$ 467.616 Millions
Mimedx Group Inc	14.82 %	$ 16.748 Millions	$ 113.006 Millions
Stryker Corp	14.18 %	$ 859.000 Millions	$ 6,057.000 Millions
Electromed Inc	13.19 %	$ 2.136 Millions	$ 16.197 Millions
Steris Plc	13.18 %	$ 192.500 Millions	$ 1,460.300 Millions
Penumbra Inc	12.93 %	$ 45.851 Millions	$ 354.685 Millions
3m Company	12.90 %	$ 841.000 Millions	$ 6,517.000 Millions
Insulet Corporation	12.40 %	$ 87.600 Millions	$ 706.300 Millions
Haemonetics Corporation	11.84 %	$ 38.684 Millions	$ 326.744 Millions
Zimmer Biomet Holdings Inc	11.55 %	$ 231.200 Millions	$ 2,001.400 Millions
Interpace Biosciences Inc	10.80 %	$ 0.911 Millions	$ 8.439 Millions
Medinotec Inc	10.71 %	$ 0.347 Millions	$ 3.236 Millions
Ufp Technologies Inc	10.66 %	$ 16.383 Millions	$ 153.747 Millions
Fonar Corporation	10.25 %	$ 2.670 Millions	$ 26.043 Millions

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.